Network of vascular diseases, death and biochemical characteristics in a set of 4,197 patients with type 1 diabetes (The FinnDiane Study)

Cardiovascular Diabetology

Volumn 8, Issue , 2009, Pages 54-

  Mäkinen, Ville Petteri ^a,b,c   Forsblom, Carol ^a,b   Thorn, Lena M ^a,b   Wadén, Johan ^a,b   Kaski, Kimmo ^c   Ala Korpela, Mika ^d,e   Groop, Per Henrik ^a,b,f  

^a FOLKHÄLSAN INSTITUTE OF GENETICS   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c AALTO UNIVERSITY   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e UNIVERSITY OF OULU   (Finland)

^f BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPOPROTEIN; POTASSIUM; TRIACYLGLYCEROL;

ADULT; AGING; ALBUMINURIA; ARTICLE; BIOCHEMISTRY; BLOOD PRESSURE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEATH; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; FINLAND; FOLLOW UP; HEALTH CENTER; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; POTASSIUM BLOOD LEVEL; PROTEIN METABOLISM; URINALYSIS; URINARY EXCRETION;

BIOCHEMICAL PHENOMENA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; FINLAND; HUMANS; MALE; METABOLIC NETWORKS AND PATHWAYS; MORTALITY; VASCULAR DISEASES;

EID: 70449516720     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-8-54     Document Type: Article

References (47)

1. Finne P, Reunanen A, Stenman S, Groop PH, Grönhagen-Riska C. Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA 2005, 294:1782-1787. 10.1001/jama.294.14.1782, 16219881.
2. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 2005, 28:164-176. 10.2337/diacare.28.1.164, 15616252.
3. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001, 44(Suppl 2):S14-21. 10.1007/PL00002934, 11587045.
4. Kim WY, Astrup AS, Stuber M, Tarnow L, Falk E, Botnar RM, Simonsen C, Pietraszek L, Hansen PR, Manning WJ, Andersen NT, Parving H. Subclinical coronary and aortic atherosclerosis detected by magnetic resonance imaging in type 1 diabetes with and without diabetic nephropathy. Circulation 2007, 115:228-235. 10.1161/CIRCULATIONAHA.106.633339, 17190865.
5. Lopes-Virella MF, Carter RE, Gilbert GE, Klein RL, Jaffa M, Jenkins AJ, Lyons TJ, Garvey WT, Virella G. Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications. Diabetes Care 2008, 31:2006-2012. 10.2337/dc08-0659, 2551645, 18628568.
6. Soedamah-Muthu SS, Chaturvedi N, Witte DR, Stevens LK, Porta M, Fuller JH. Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS). Diabetes Care 2008, 31:1360-1366. 10.2337/dc08-0107, 2453640, 18375412.
7. Thorn LM, Forsblom C, Fagerudd J, Pettersson-Fernholm K, Kilpikari R, Groop PH. Clustering of risk factors in parents of patients with type 1 diabetes and nephropathy. Diabetes Care 2007, 30:1162-1167. 10.2337/dc06-2033, 17337502.
8. Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with type II diabetes. Diabetologia 2000, 43:148-155. 10.1007/s001250050023, 10753035.
9. Mayer-Davis EJ, Ma B, Lawson A, D'Agostino RB, Liese AD, Bell RA, Dabelea D, Dolan L, Pettitt DJ, Rodriguez BL, Williams D. Cardiovascular disease risk factors in youth with type 1 and type 2 diabetes: implications of a factor analysis of clustering. Metab Syndr Relat Disord 2008, 7:89-95.
10. Zethelius B, Berglund L, Sundström J, Ingelsson E, Basu S, Larsson A, Venge P, Arnlöv J. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 2008, 358:2107-2116. 10.1056/NEJMoa0707064, 18480203.
11. Barabasi A, Albert R. Emergence of scaling in random networks. Science 1999, 286:509-512. 10.1126/science.286.5439.509, 10521342.
12. Pawson T, Linding R. Network medicine. FEBS Lett 2008, 582:1266-1270. 10.1016/j.febslet.2008.02.011, 18282479.
13. Onnela J, Saramäki J, Hyvönen J, Szabó G, Lazer D, Kaski K, Kertész J, Barabási A. Structure and tie strengths in mobile communication networks. Proc Natl Acad Sci USA 2007, 104:7332-7336. 10.1073/pnas.0610245104, 1863470, 17456605.
14. Palla G, Barabási A, Vicsek T. Quantifying social group evolution. Nature 2007, 446:664-667. 10.1038/nature05670, 17410175.
15. Pieroni E, de la Fuente van Bentem S, Mancosu G, Capobianco E, Hirt H, de la Fuente A. Protein networking: insights into global functional organization of proteomes. Proteomics 2008, 8:799-816. 10.1002/pmic.200700767, 18297653.
16. Lee D, Park J, Kay KA, Christakis NA, Oltvai ZN, Barabási A. The implications of human metabolic network topology for disease comorbidity. Proc Natl Acad Sci USA 2008, 105:9880-9885. 10.1073/pnas.0802208105, 2481357, 18599447.
17. Saramäki J, Kaski K. Modelling development of epidemics with dynamic small-world networks. J Theor Biol 2005, 234:413-421. 10.1016/j.jtbi.2004.12.003, 15784275.
18. James A, Pitchford JW, Plank MJ. An event-based model of superspreading in epidemics. Proc Biol Sci 2007, 274:741-747. 10.1098/rspb.2006.0219, 2197209, 17255000.
19. Nils Weskamp N, Hullermeier E, Klebe G. Merging chemical and biological space: structural mapping of enzyme binding pocket space. Proteins 2009, 76:317-330. 10.1002/prot.22345, 19173307.
20. Bhattacharya K, Mukherjee G, Saramäki J, Kaski K, Manna S. The international trade network: weighted network analysis and modelling. J Stat Mech 2008, P02002.
21. Niemi J, Mäkinen VP, Heikkonen J, Tenkanen L, Hiltunen Y, Hannuksela M, Jauhiainen M, Forsblom C, Taskinen M, Kesäniemi Y, Savolainen M, Kaski K, Groop PH, Kovanen P, Ala-Korpela M. Estimation of VLDL, IDL, LDL, HDL2, apoA-I and apoB from the Friedewald inputs - apoB and IDL, but not LDL, are associated with mortality in type 1 diabetes. Ann Med 2009, 1-11.
22. Mäkinen VP, Forsblom C, Thorn LM, Wadén J, Gordin D, Heikkilä O, Hietala K, Kyllönen L, Kytö J, Rosengård-Bärlund M, Saraheimo M, Tolonen N, Parkkonen M, Kaski K, Ala-Korpela M, Groop PH. Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes. Diabetes 2008, 57:2480-2487. 10.2337/db08-0332, 2518500, 18544706.
23. Tumminello M, Aste T, Di Matteo T, Mantegna RN. A tool for filtering information in complex systems. Proc Natl Acad Sci USA 2005, 102:10421-10426. 10.1073/pnas.0500298102, 1180754, 16027373.
24. Onnela J, Chakraborti A, Kaski K, Kertesz J. Dynamic asset trees and black monday. Physica A 2003, 324:227-252.
25. Davidson MH, Toth PP. High-density lipoprotein metabolism: potential therapeutic targets. Am J Cardiol 2007, 100:32-40.
26. The Diabetes Control and Complications Trial The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977-986. 10.1056/NEJM199309303291401, 8366922.
27. The Diabetes Control and Complications Trial and Follow-up Study Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000, 342:381-386. 10.1056/NEJM200002103420603, 2630213, 10666428.
28. Wadén J, Forsblom C, Thorn LM, Gordin D, Saraheimo M, Groop PH. A1c variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes. Diabetes DOI:10.2337/db09-0693.
29. Brownlee M. The pathological implications of protein glycation. Clin Invest Med 1995, 18:275-281.
30. Lindholm E, Hallengren B, Agardh C. Gender differences in gad antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases. Diabetes Metab Res Rev 2004, 20:158-164. 10.1002/dmrr.420, 15037992.
31. Mäkinen VP, Soininen P, Forsblom C, Parkkonen M, Ingman P, Kaski K, Groop P, Ala-Korpela M. 1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death. Mol Syst Biol 2008, 4:167. 10.1038/msb4100205, 2267737, 18277383.
32. Chaturvedi N, Fuller JH, Taskinen MR. Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes. Diabetes Care 2001, 24:2071-2077. 10.2337/diacare.24.12.2071, 11723085.
33. Groop PH, Elliott T, Ekstrand A, Franssila-Kallunki A, Friedman R, Viberti GC, Taskinen MR. Multiple lipoprotein abnormalities in type i diabetic patients with renal disease. Diabetes 1996, 45:974-979. 10.2337/diabetes.45.7.974, 8666151.
34. Groop PH, Thomas MC, Rosengård-Bärlund M, Mills V, Rönnback M, Thomas S, Forsblom C, Taskinen M, Viberti G. HDL composition predicts new-onset cardiovascular disease in patients with type 1 diabetes. Diabetes Care 2007, 30:2706-2707. 10.2337/dc07-0030, 17620444.
35. Ikewaki K, Schaefer JR, Frischmann ME, Okubo K, Hosoya T, Mochizuki S, Dieplinger B, Trenkwalder E, Schweer H, Kronenberg F, Koenig P, Dieplinger H. Delayed in vivo catabolism of intermediate-density lipoprotein and low-density lipoprotein in hemodialysis patients as potential cause of premature atherosclerosis. Arterioscler Thromb Vasc Biol 2005, 25:2615-2622. 10.1161/01.ATV.0000188555.60475.c2, 16195474.
36. Yang X, Ma RC, So W, Ko GT, Kong AP, Lam CW, Ho C, Cockram CS, Wong VC, Tong PC, Chan JC. Impacts of chronic kidney disease and albuminuria on associations between coronary heart disease and its traditional risk factors in type 2 diabetic patients - the Hong Kong Diabetes Registry. Cardiovasc Diabetol 2007, 6:37. 10.1186/1475-2840-6-37, 2219954, 18053157.
37. Steinberg GR. Inflammation in obesity is the common link between defects in fatty acid metabolism and insulin resistance. Cell Cycle 2007, 6:888-894.
38. Goldfine AB, Kahn CR. Adiponectin: linking the fat cell to insulin sensitivity. Lancet 2003, 362:1431-1432. 10.1016/S0140-6736(03)14727-7, 14602433.
39. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003, 46:459-469.
40. Saraheimo M, Forsblom C, Thorn L, Wadén J, Rosengård-Bärlund M, Heikkilä O, Hietala K, Gordin D, Frystyk J, Flyvbjerg A, Groop P. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes. Diabetes Care 2008, 31:1165-1169. 10.2337/dc07-2306, 18346990.
41. Stenvinkel P, Marchlewska A, Pecoits-Filho R, Heimbürger O, Zhang Z, Hoff C, Holmes C, Axelsson J, Arvidsson S, Schalling M, Barany P, Lindholm B, Nordfors L. Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin. Kidney Int 2004, 65:274-281. 10.1111/j.1523-1755.2004.00370.x, 14675060.
42. Groop PH, Forsblom C, Thomas MC. Mechanisms of disease: pathway-selective insulin resistance and microvascular complications of diabetes. Nat Clin Pract Endocrinol Metab 2005, 1:100-110. 10.1038/ncpendmet0046, 16929378.
43. Giannattasio C, Failla M, Piperno A, Grappiolo A, Gamba P, Paleari F, Mancia G. Early impairment of large artery structure and function in type I diabetes mellitus. Diabetologia 1999, 42:987-994. 10.1007/s001250051257, 10491759.
44. Rönnback M, Fagerudd J, Forsblom C, Pettersson-Fernholm K, Reunanen A, Groop PH. Altered age-related blood pressure pattern in type 1 diabetes. Circulation 2004, 110:1076-1082. 10.1161/01.CIR.0000139903.29522.8D, 15326070.
45. Thomas MC, Atkins RC. Blood pressure lowering for the prevention and treatment of diabetic kidney disease. Drugs 2006, 66:2213-2234. 10.2165/00003495-200666170-00005, 17137404.
46. La Rocca E, Fiorina P, di Carlo V, Astorri E, Rossetti C, Lucignani G, Fazio F, Giudici D, Cristallo M, Bianchi G, Pozza G, Secchi A. Cardiovascular outcomes after kidney-pancreas and kidney-alone transplantation. Kidney Int 2001, 60:1964-1971. 10.1046/j.1523-1755.2001.00008.x, 11703616.
47. Himmeli graph drawing software. , http://www.finndiane.fi/software/